Search
ZOLADEX 10.8 MG, Implant injectable
Details
| --- | Description |
|---|---|
| Pack | 1 Seringue préremplie |
| Strength (Dosage) | 10.8 MG |
| Laboratory | MAPHAR |
| Ingredients | Goséréline |
| Therapeutic class | ANTINEOPLASIQUES CYTOTOXIQUES |
| ATC code | L02AE03 |
| PPH | $302.60 |
| PPV | $334.00 |
| Refundable | Yes |
| Refund base | $334.00 |
| Refund rate | $0.00 |
| Table | |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Zoladex est indiqué chez l’adulte dans le : · Traitement du cancer de la prostate métastasé. · Traitement adjuvant à la radiothérapie externe dans le cancer de la prostate localement avancé (stade T3 -T4 de la classification TNM ou stade C de la classification AUA). |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem